Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Deloitte
Deloitte Agrees to Acquire Recombinant Capital, a Leading Life Sciences Subscription Database and Advisory Services Firm
July 5th, 2008
Deloitte has announced an agreement to acquire Recombinant Capital, Inc. (Recap), a leading life sciences subscription database and advisory services firm. Included in the acquisition is Recap's unique database that provides more than 1,500 subscribers with access to over 20 years of historical data used to track significant publicly available information in the life sciences industry, ranging from alliance formations to intellectual property ownership and clinical trials data. Deloitte's life sciences consulting practice was ranked number one by Kennedy Information in 2007 in terms of revenue and market share. Deloitte will further reinforce its market leadership...
Source: Law & Health Weekly (2008-07-05)
|
